Tremfya on Humana Value Rx Plan (S5884-189)
guselkumab
Covered, with prior authorization required.
Tier 5 (specialty tier). Quantity limit of 3 per 84 days.
$3,868.59
Patient pays / month, after deductible
$4,313.33
Patient pays / month, before the $601.00 deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
TREMFYA 100 mg/mL Injection at a preferred retail pharmacy, from the plan's negotiated price of $14,879.20 for a month. Other covered strengths are listed below.
Prior authRequired on all 5 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 5 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| TREMFYA 100 mg/mL Injection | 5 | $3,877.05 | PA · 3 per 84 days |
| TREMFYA 100 mg/mL Injection | 5 | $3,868.59 | PA · 3 per 84 days |
| TREMFYA 200 mg/2mL Injection | 5 | $7,952.77 | PA · 4 per 28 days |
| TREMFYA 200 mg/2mL Injection | 5 | $7,952.77 | PA · 4 per 28 days |
| TREMFYA 200 mg/2mL Injection | 5 | $7,952.77 | PA · 4 per 28 days |
Other IL-17 and IL-23 biologics on this plan
Verify with the plan before prescribing or filling. Member services: (800)281-6918. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5884-189